Author

Mary Helen Barcellos‐Hoff

University of California, San FranciscoORCID 0000-0002-5994-9558Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexis J. CombesiD· 1 shared Ann LazariD· 1 shared Inés Guix· 1 shared Jade MooreiD· 1 shared Jim GkantalisiD· 1 shared Kobe Chi Yung YueniD· 1 shared Matthew H. SpitzeriD· 1 shared William S. ChouiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexis J. CombesORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of a conserved subset of cold tumors responsive to immune checkpoint blockade

Jade Moore, Jim Gkantalis, Inés Guix, William S. Chou, Kobe Chi Yung Yuen, Ann Lazar, Matthew H. Spitzer, Alexis J. Combes, Mary Helen Barcellos‐Hoff

This study identifies a biomarker, {beta}Alt, that predicts immune checkpoint blockade response in cold tumors by integrating TGF{beta} signaling, DNA repair, and immune context signatures.

Journal for ImmunoTherapy of Cancer · Mar 1, 2025Peer-reviewedCancer Biology